nodes	percent_of_prediction	percent_of_DWPC	metapath
Clobetasol propionate—Application site burn—Fluorouracil—colon cancer	0.0821	0.0848	CcSEcCtD
Clobetasol propionate—Telangiectasia—Fluorouracil—colon cancer	0.073	0.0754	CcSEcCtD
Clobetasol propionate—Rosacea—Capecitabine—colon cancer	0.055	0.0569	CcSEcCtD
Clobetasol propionate—Allergic contact dermatitis—Fluorouracil—colon cancer	0.0492	0.0509	CcSEcCtD
Clobetasol propionate—Application site pain—Fluorouracil—colon cancer	0.0391	0.0404	CcSEcCtD
Clobetasol propionate—Telangiectasia—Methotrexate—colon cancer	0.038	0.0392	CcSEcCtD
Clobetasol propionate—Application site reaction—Fluorouracil—colon cancer	0.0367	0.0379	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Fluorouracil—colon cancer	0.0289	0.0299	CcSEcCtD
Clobetasol propionate—Tingling sensation—Fluorouracil—colon cancer	0.0214	0.0221	CcSEcCtD
Clobetasol propionate—Stinging—Fluorouracil—colon cancer	0.0212	0.0219	CcSEcCtD
Clobetasol propionate—Leukoderma—Methotrexate—colon cancer	0.021	0.0217	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Capecitabine—colon cancer	0.0202	0.0209	CcSEcCtD
Clobetasol propionate—Eye irritation—Fluorouracil—colon cancer	0.0201	0.0208	CcSEcCtD
Clobetasol propionate—Tenderness—Fluorouracil—colon cancer	0.0197	0.0204	CcSEcCtD
Clobetasol propionate—Dermatitis contact—Fluorouracil—colon cancer	0.017	0.0176	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Methotrexate—colon cancer	0.015	0.0155	CcSEcCtD
Clobetasol propionate—Tingling sensation—Capecitabine—colon cancer	0.0149	0.0154	CcSEcCtD
Clobetasol propionate—Eruption—Methotrexate—colon cancer	0.0145	0.015	CcSEcCtD
Clobetasol propionate—Psoriasis—Methotrexate—colon cancer	0.0142	0.0147	CcSEcCtD
Clobetasol propionate—Folliculitis—Methotrexate—colon cancer	0.0142	0.0147	CcSEcCtD
Clobetasol propionate—Eye irritation—Capecitabine—colon cancer	0.0141	0.0145	CcSEcCtD
Clobetasol propionate—Pain in extremity—Vincristine—colon cancer	0.0134	0.0138	CcSEcCtD
Clobetasol propionate—Dry skin—Fluorouracil—colon cancer	0.0114	0.0118	CcSEcCtD
Clobetasol propionate—Vascular purpura—Capecitabine—colon cancer	0.00975	0.0101	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Vincristine—colon cancer	0.00921	0.00952	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Vincristine—colon cancer	0.0091	0.0094	CcSEcCtD
Clobetasol propionate—Purpura—Capecitabine—colon cancer	0.00905	0.00935	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Irinotecan—colon cancer	0.00886	0.00916	CcSEcCtD
Clobetasol propionate—Pain in extremity—Capecitabine—colon cancer	0.00872	0.00901	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Fluorouracil—colon cancer	0.00859	0.00888	CcSEcCtD
Clobetasol propionate—Alopecia—Vincristine—colon cancer	0.00818	0.00845	CcSEcCtD
Clobetasol propionate—Dry skin—Capecitabine—colon cancer	0.00799	0.00826	CcSEcCtD
Clobetasol propionate—Alopecia—Irinotecan—colon cancer	0.00797	0.00823	CcSEcCtD
Clobetasol propionate—Alopecia—Fluorouracil—colon cancer	0.00763	0.00788	CcSEcCtD
Clobetasol propionate—Erythema—Fluorouracil—colon cancer	0.00752	0.00777	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Capecitabine—colon cancer	0.0068	0.00703	CcSEcCtD
Clobetasol propionate—Infection—Vincristine—colon cancer	0.00653	0.00675	CcSEcCtD
Clobetasol propionate—Infection—Irinotecan—colon cancer	0.00636	0.00658	CcSEcCtD
Clobetasol propionate—Infection—Fluorouracil—colon cancer	0.00609	0.0063	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Capecitabine—colon cancer	0.006	0.0062	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Capecitabine—colon cancer	0.00594	0.00614	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Capecitabine—colon cancer	0.00593	0.00613	CcSEcCtD
Clobetasol propionate—Paraesthesia—Vincristine—colon cancer	0.00591	0.0061	CcSEcCtD
Clobetasol propionate—Paraesthesia—Irinotecan—colon cancer	0.00575	0.00594	CcSEcCtD
Clobetasol propionate—Fluticasone furoate—ABCB1—colon cancer	0.00572	0.177	CrCbGaD
Clobetasol propionate—Pain—Vincristine—colon cancer	0.00562	0.00581	CcSEcCtD
Clobetasol propionate—Paraesthesia—Fluorouracil—colon cancer	0.00551	0.00569	CcSEcCtD
Clobetasol propionate—Pain—Irinotecan—colon cancer	0.00548	0.00566	CcSEcCtD
Clobetasol propionate—Alopecia—Capecitabine—colon cancer	0.00533	0.00551	CcSEcCtD
Clobetasol propionate—Erythema—Capecitabine—colon cancer	0.00525	0.00543	CcSEcCtD
Clobetasol propionate—Pain—Fluorouracil—colon cancer	0.00525	0.00542	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Vincristine—colon cancer	0.00485	0.00501	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Irinotecan—colon cancer	0.00472	0.00488	CcSEcCtD
Clobetasol propionate—Methylprednisolone—ABCB1—colon cancer	0.00456	0.141	CrCbGaD
Clobetasol propionate—Triamcinolone—PTGS2—colon cancer	0.00452	0.14	CrCbGaD
Clobetasol propionate—Hypersensitivity—Fluorouracil—colon cancer	0.00452	0.00467	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00444	0.00459	CcSEcCtD
Clobetasol propionate—Pruritus—Fluorouracil—colon cancer	0.00434	0.00449	CcSEcCtD
Clobetasol propionate—Infection—Capecitabine—colon cancer	0.00426	0.0044	CcSEcCtD
Clobetasol propionate—Skin disorder—Capecitabine—colon cancer	0.00416	0.0043	CcSEcCtD
Clobetasol propionate—Rash—Vincristine—colon cancer	0.00415	0.00429	CcSEcCtD
Clobetasol propionate—Dermatitis—Vincristine—colon cancer	0.00414	0.00428	CcSEcCtD
Clobetasol propionate—Headache—Vincristine—colon cancer	0.00412	0.00426	CcSEcCtD
Clobetasol propionate—Rash—Irinotecan—colon cancer	0.00404	0.00417	CcSEcCtD
Clobetasol propionate—Dermatitis—Irinotecan—colon cancer	0.00403	0.00417	CcSEcCtD
Clobetasol propionate—Headache—Irinotecan—colon cancer	0.00401	0.00415	CcSEcCtD
Clobetasol propionate—Alopecia—Methotrexate—colon cancer	0.00397	0.0041	CcSEcCtD
Clobetasol propionate—Erythema—Methotrexate—colon cancer	0.00391	0.00404	CcSEcCtD
Clobetasol propionate—Rash—Fluorouracil—colon cancer	0.00387	0.004	CcSEcCtD
Clobetasol propionate—Dermatitis—Fluorouracil—colon cancer	0.00386	0.00399	CcSEcCtD
Clobetasol propionate—Paraesthesia—Capecitabine—colon cancer	0.00385	0.00398	CcSEcCtD
Clobetasol propionate—Headache—Fluorouracil—colon cancer	0.00384	0.00397	CcSEcCtD
Clobetasol propionate—Betamethasone—PTGS2—colon cancer	0.0037	0.115	CrCbGaD
Clobetasol propionate—Pain—Capecitabine—colon cancer	0.00367	0.00379	CcSEcCtD
Clobetasol propionate—Prednisone—ABCB1—colon cancer	0.00349	0.108	CrCbGaD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00331	0.00342	CcSEcCtD
Clobetasol propionate—Prednisolone—ABCB1—colon cancer	0.00321	0.0994	CrCbGaD
Clobetasol propionate—Infection—Methotrexate—colon cancer	0.00317	0.00328	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Capecitabine—colon cancer	0.00316	0.00326	CcSEcCtD
Clobetasol propionate—Betamethasone—ABCB1—colon cancer	0.00315	0.0974	CrCbGaD
Clobetasol propionate—Skin disorder—Methotrexate—colon cancer	0.0031	0.0032	CcSEcCtD
Clobetasol propionate—Pruritus—Capecitabine—colon cancer	0.00303	0.00313	CcSEcCtD
Clobetasol propionate—Paraesthesia—Methotrexate—colon cancer	0.00287	0.00296	CcSEcCtD
Clobetasol propionate—Pain—Methotrexate—colon cancer	0.00273	0.00282	CcSEcCtD
Clobetasol propionate—Rash—Capecitabine—colon cancer	0.0027	0.00279	CcSEcCtD
Clobetasol propionate—Dermatitis—Capecitabine—colon cancer	0.0027	0.00279	CcSEcCtD
Clobetasol propionate—Headache—Capecitabine—colon cancer	0.00269	0.00278	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Methotrexate—colon cancer	0.00235	0.00243	CcSEcCtD
Clobetasol propionate—Pruritus—Methotrexate—colon cancer	0.00226	0.00233	CcSEcCtD
Clobetasol propionate—Dexamethasone—PTGS2—colon cancer	0.00215	0.0666	CrCbGaD
Clobetasol propionate—Rash—Methotrexate—colon cancer	0.00201	0.00208	CcSEcCtD
Clobetasol propionate—Dermatitis—Methotrexate—colon cancer	0.00201	0.00208	CcSEcCtD
Clobetasol propionate—Headache—Methotrexate—colon cancer	0.002	0.00207	CcSEcCtD
Clobetasol propionate—Dexamethasone—ABCB1—colon cancer	0.00183	0.0567	CrCbGaD
